Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
Simone M, Lucisano G, Guerra T, Paolicelli D, Rocca MA, Brescia Morra V, Patti F, Annovazzi P, Gasperini C, De Luca G, Ferraro D, Margari L, Granella F, Pozzilli C, Romano S, Perini P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Lugaresi A, Portaccio E, Filippi M, Amato MP, Iaffaldano P; Italian Multiple Sclerosis Register. Simone M, et al. Among authors: paolicelli d. J Neurol. 2024 Oct;271(10):6782-6790. doi: 10.1007/s00415-024-12638-0. Epub 2024 Aug 23. J Neurol. 2024. PMID: 39179712 Free PMC article.
Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study.
Borriello G, Chisari CG, Maimone D, Mirabella M, Paolicelli D, Assogna F, Caradonna S, Patti F. Borriello G, et al. Among authors: paolicelli d. Front Neurol. 2024 Jul 18;15:1422078. doi: 10.3389/fneur.2024.1422078. eCollection 2024. Front Neurol. 2024. PMID: 39114529 Free PMC article.
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project.
Paolicelli D, Borriello G, Clerici R, Colombo E, Croce D, D'Amico E, De Rossi N, Di Sapio A, Fenu G, Maimone D, Marfia GA, Moccia M, Perini P, Piscaglia MG, Razzolini L, Riccaboni M, Signoriello E, Agostoni G, Farina A, Mondino M, Berruto F, Tettamanti A, Donnaloja F, Tortorella C. Paolicelli D, et al. Neurol Ther. 2024 Oct;13(5):1415-1430. doi: 10.1007/s40120-024-00644-3. Epub 2024 Aug 2. Neurol Ther. 2024. PMID: 39093539 Free PMC article.
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.
Iaffaldano P, Lucisano G, Guerra T, Paolicelli D, Portaccio E, Inglese M, Foschi M, Patti F, Granella F, Romano S, Cavalla P, De Luca G, Gallo P, Bellantonio P, Gallo A, Montepietra S, Di Sapio A, Vianello M, Quatrale R, Spitaleri D, Clerici R, Torri Clerici V, Cocco E, Brescia Morra V, Marfia GA, Boccia VD, Filippi M, Amato MP, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: paolicelli d. Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5. Ann Clin Transl Neurol. 2024. PMID: 38970214 Free PMC article.
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing.
Manni A, Oggiano F, Palazzo C, Panetta V, Gargano CD, Mangialardi V, Guerra T, Iaffaldano A, Caputo F, Iaffaldano P, Ruggieri M, Trojano M, Paolicelli D. Manni A, et al. Among authors: paolicelli d. J Neurol Sci. 2024 Jul 15;462:123070. doi: 10.1016/j.jns.2024.123070. Epub 2024 May 29. J Neurol Sci. 2024. PMID: 38850773 Free article.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Chisari CG, Aguglia U, Amato MP, Bergamaschi R, Bertolotto A, Bonavita S, Morra VB, Cavalla P, Cocco E, Conte A, Cottone S, De Luca G, Di Sapio A, Filippi M, Gallo A, Gasperini C, Granella F, Lus G, Maimone D, Maniscalco GT, Marfia G, Moiola L, Paolicelli D, Pesci I, Ragonese P, Rovaris M, Salemi G, Solaro C, Totaro R, Trojano M, Vianello M, Zaffaroni M, Lepore V, Patti F; Italian MS Register Study Group. Chisari CG, et al. Among authors: paolicelli d. Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7. Neurotherapeutics. 2024. PMID: 38714462 Free PMC article.
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.
Mallucci G, Ferraro OE, Trojano M, Amato MP, Scalfari A, Zaffaroni M, Colombo E, Rigoni E, Iaffaldano P, Portaccio E, Saraceno L, Paolicelli D, Razzolini L, Montomoli C, Bergamaschi R. Mallucci G, et al. Among authors: paolicelli d. J Neurol. 2024 Jun;271(6):3496-3505. doi: 10.1007/s00415-024-12304-5. Epub 2024 Mar 26. J Neurol. 2024. PMID: 38532143
151 results